“As researchers look for new ways to fight cancer, lutetium-177 has been turned to as a way to treat patients in a non-invasive way,” added Chief Lester Anoquot, Chippewas of Saugeen First Nation. “This project is coming online when demand for treatments is increasing daily, and it will provide a much-needed source of these isotopes for patients close to home, in our communities, and around the world.”
With this milestone now achieved, commissioning activities will be completed this summer and will be followed by commercial operations, pending final regulatory review and approval by the Canadian Nuclear Safety Commission (CNSC).
Back to HCB News
Ad Statistics
Times Displayed: 31443
Times Visited: 833 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
